Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: Ansuvimab [USAN]
RN: 2375952-29-5
UNII: TG8IQ19NG2

Molecular Formula

  • C6368-H9924-N1724-O1994-S44.(non-glycosylated)
 

Classification Codes

  • Anti-Infective Agents
  • Antiviral Agents
  • Treatment of Ebola Virus
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Ansuvimab [USAN]

Synonyms

  • Ansuvimab
  • Ansuvimab-zykl
  • Ebanga
  • EboV mAb114
  • Immunoglobulin G1-kappa, anti-(Zaire ebolavirus Envelope glycoprotein GP1 subunit glycan cap domain(subunit (III)); human monoclonal antibody; gamma1 heavy chain (1-449) (Homo sapiens VH (IGHVV3-13*01 (78%) –(IGHD)-IGHJ5*01 (93%)) (8.7.13) (1-119) -Homo sapiens IGHG1*01 (120-449)), (222-214')-disulfide with kappa light chain (1'-214') (Homo sapiens V-KAPPA (Homo sapiens IGKV1-27*01 (87%) –IGKJ4*01)(6.3.9) (1'-108') -Homo sapiens IGKC*01 (109'-214')), dimer (228-228'':231-231'')-bisdisulfide
  • mAb-114
  • MAB114
  • UNII-TG8IQ19NG2
  • VRC-EBOMAB092-00-AB
  • WHO 11568

Systematic Name

  • Immunoglobulin G1, anti-(Zaire ebolavirus glycoprotein glycan cap and GP1 domain) (human monoclonal mAb114 gamma1-chain), disulfide with human monoclonal mAb114 kappa-chain, dimer

Registry Numbers

CAS Registry Number

  • 2375952-29-5

FDA UNII

  • TG8IQ19NG2

System Generated Number

  • 2375952295